Moderna Expands Horizons With Vertex and Chiesi Deals

Pacts Come Ahead Of R&D Day

 
• By Andrew McConaghie

The world is waiting for Moderna’s COVID-19 vaccine results, but meanwhile the company is exploring new avenues to secure long-term growth

Moderna_Pills_Syringe
The two new alliances bring in $100m in upfront payments and $780m in potential milestones plus royalties.

More from Business

More from Scrip